Kathman_2020_ACS.Chem.Biol_15_871

Reference

Title : Blockade of the Lysophosphatidylserine Lipase ABHD12 Potentiates Ferroptosis in Cancer Cells - Kathman_2020_ACS.Chem.Biol_15_871
Author(s) : Kathman SG , Boshart J , Jing H , Cravatt BF
Ref : ACS Chemical Biology , 15 :871 , 2020
Abstract :

Ferroptosis is a type of cell death caused by the pathogenic accumulation of lipid hydroperoxides. Pharmacological mechanisms to induce ferroptosis may provide a way to kill cancer cells that are resistant to other forms of cell death like apoptosis. Nonetheless, the proteins that regulate ferroptotic sensitivity in cancer cells remain incompletely understood. Here, we screened a panel of inhibitors of serine hydrolases-an enzyme class important for regulating lipid metabolism-for potentiation of ferroptosis in HT1080 fibrosarcoma cells. We found that DO264, a selective inhibitor of the lyso- and ox-phosphatidylserine (PS) lipase ABHD12, enhances ferroptotic death caused by RSL3, an inhibitor of the lipid peroxidase GPX4. RSL3-induced ferroptosis was also potentiated by genetic disruption of ABHD12. Metabolomic experiments revealed that, in addition to elevated lyso-PS, ABHD12-inactivated cells show higher quantities of arachidonate (C20:4)-containing PS and 2-arachidonoyl glycerol, pointing to potential oxidation-sensitive lipid mediators of ferroptosis regulated by ABHD12.

PubMedSearch : Kathman_2020_ACS.Chem.Biol_15_871
PubMedID: 32195565
Gene_locus related to this paper: human-ABHD12

Related information

Inhibitor DO264
Gene_locus human-ABHD12

Citations formats

Kathman SG, Boshart J, Jing H, Cravatt BF (2020)
Blockade of the Lysophosphatidylserine Lipase ABHD12 Potentiates Ferroptosis in Cancer Cells
ACS Chemical Biology 15 :871

Kathman SG, Boshart J, Jing H, Cravatt BF (2020)
ACS Chemical Biology 15 :871